home > pmps > winter 2017 > out with the old
Pharmaceutical Manufacturing and Packing Sourcer

Out With the Old

What a year 2016 has been. The Year of the Monkey certainly lived up to the mischievous nature of the animal with 2016 having been possibly the most unpredictable year in living memory. If someone had placed a £1 bet a year ago on Leicester City winning the Premier League, the UK voting to leave the EU and Donald Trump being elected as the next president of the US, then they would have picked up £4.5 million from the bookmaker!

What Will 2017 Bring?

The next year is sure to see the repercussions of Brexit continuing to cause unrest within the pharma industry. The nature of the relationship between Britain and the EU will not be decided in 2017, but investment strategies will most definitely be influenced by the inevitability of changes to business and regulatory practices between the two and, of course, the question over the freedom of movement of workers within the EU.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
Robert Harris is Chief Technical Officer at Juniper Pharma Services and PMPS Industry Advisor
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research

Philadelphia and London – June 10, 2019: CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health ( Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable sponsors and CROs to extend the reach of drug development, expand patient opportunities and improve data quality.
More info >>

White Papers

7 Common Myths about QP Training Debunked: A Guide for Senior Managers


The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >>

Industry Events



SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement